Enerpac’s Q2 Sales Rise 6% to $154.8M; Adjusted EPS $0.39
Enerpac reported Q2 net sales of $154.8 million, up 6% year-over-year (2% organic) and beating the $147.8 million consensus, while adjusted EPS matched expectations at $0.39. The company repurchased $51 million of shares, won a five-year UK oil & gas service contract and narrowed full-year EPS guidance to $1.85-$1.92.
1. Q2 Financial Results
Enerpac recorded net sales of $154.8 million for fiscal Q2, a 6% increase from the prior year and above the $147.8 million consensus. GAAP net earnings were $16.3 million, or $0.31 per share, while adjusted net earnings reached $20.3 million, or $0.39 per share.
2. Segment Performance
Within the Industrial Tool & Service segment, product sales rose 6% organically—the strongest gain in ten quarters—while service revenue fell 17% organically, driven by softer demand in EMEA. Cortland Biomedical sales grew 27% organically, and the company secured a five-year UK oil and gas service contract worth several million dollars annually.
3. Capital Allocation and Cash Flow
Enerpac generated $29 million in operating cash flow year to date, up from $16 million last year, and returned $51 million to shareholders through share repurchases of approximately 1.3 million shares. The buyback underscores management’s focus on capital discipline and shareholder value.
4. Outlook and Guidance
For full-year fiscal 2026, Enerpac narrowed its adjusted EPS guidance to $1.85–$1.92 and projects net sales of $635–$650 million with 1–3% organic growth. The company expects adjusted EBITDA of $158–$163 million and free cash flow of $100–$110 million.